In the News
Why Causal Learning is a Superpower for Healthcare
Most people have never heard of causal learning, but the concept is an important one for the future of healthcare because it holds the key to understanding and fighting disease and improving outcomes. However, to understand how and why causality is so important in the...
read more
In Silico in Sight as Biopharma Game-Changer
Pharmaceutical Executive reporter discusses how a coalition of data, computational power, and AI is bringing the full potential of in silico medicine out of the realm of science fiction. Read the full story here.
read more
GNS Healthcare, MMRF Bring Patient Simulations to Multiple Myeloma Precision Treatment, Trial Design
Precision Oncology News reporter discusses Gemini and its prospective impact on multiple myeloma. Read more here.
read moreEvents
Colin Hill to Speak at The Longwood Healthcare Leaders Winter Webconference
On Thursday, January 6, Colin Hill, will be moderating a panel on Expediting Research for Treatments and Cures at the Longwood Healthcare Leaders winter webconference…
read more
Colin Hill to Speak at The Longwood Healthcare Leaders Conference
On Tuesday, October 5, Colin Hill will moderate a panel at the Longwood Healthcare Leaders meeting.
read moreUpcoming Fireside Chat at PMC Postponed to Spring, 2022
http://www.personalizedmedicineconference.org/schedule/ Precision Partnership: A Fireside Chat With Leaders From GNS Healthcare and the Multiple Myeloma Research Foundation
read morePress Releases
GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis
- Partnership leverages Scipher Medicine’s proprietary patient clinico-genomic data - In silico patient models enable pharmaceutical companies to understand what disease treatments work for which patients and why Somerville, Mass., and Waltham, Mass. ...
read moreGNS Healthcare Announces a Multi-Year Collaboration with a Leading US Cancer Center to Advance Precision Medicine in Oncology
Collaboration with Memorial Sloan Kettering Cancer Center’s Innovation Hub aims to answer key questions in prostate cancer patient care and accelerate discovery and development of new treatments Somerville, Mass.– October 5, 2021– GNS Healthcare (GNS), an artificial...
read moreGNS to Develop the World’s First in silico Patient For Prostate Cancer
Somerville, Mass., May 25, 2021: GNS Healthcare, an artificial intelligence company creating in silico patients that simulate drug treatment at the individual patient level, today announced plans to develop and launch Gemini — The in silico Patient™ for Prostate...
read more